Literature DB >> 17548060

Characterization of DNA methylation change in stem cell marker genes during differentiation of human embryonic stem cells.

Seungeun Yeo1, Sangkyun Jeong, Janghwan Kim, Jee-Soo Han, Yong-Mahn Han, Yong-Kook Kang.   

Abstract

Pluripotent human embryonic stem cells (hESCs) have the distinguishing feature of innate capacity to allow indefinite self-renewal. This attribute continues until specific constraints or restrictions, such as DNA methylation, are imposed on the genome, usually accompanied by differentiation. With the aim of utilizing DNA methylation as a sign of early differentiation, we probed the genomic regions of hESCs, particularly focusing on stem cell marker (SCM) genes to identify regulatory sequences that display differentiation-sensitive alterations in DNA methylation. We show that the promoter regions of OCT4 and NANOG, but not SOX2, REX1 and FOXD3, undergo significant methylation during hESCs differentiation in which SCM genes are substantially repressed. Thus, following exposure to differentiation stimuli, OCT4 and NANOG gene loci are modified relatively rapidly by DNA methylation. Accordingly, we propose that the DNA methylation states of OCT4 and NANOG sequences may be utilized as barometers to determine the extent of hESC differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548060     DOI: 10.1016/j.bbrc.2007.05.120

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

1.  A role for DNA methylation in regulation of EphA5 receptor expression in the mouse retina.

Authors:  Tihomira D Petkova; Gail M Seigel; Deborah C Otteson
Journal:  Vision Res       Date:  2010-09-25       Impact factor: 1.886

Review 2.  Epigenomics: the science of no-longer-junk DNA. Why study it in chronic kidney disease?

Authors:  Yi-An Ko; Katalin Susztak
Journal:  Semin Nephrol       Date:  2013-07       Impact factor: 5.299

3.  A role for the Werner syndrome protein in epigenetic inactivation of the pluripotency factor Oct4.

Authors:  Johanna A Smith; Abibatou M N Ndoye; Kyla Geary; Michael P Lisanti; Olga Igoucheva; René Daniel
Journal:  Aging Cell       Date:  2010-05-10       Impact factor: 9.304

4.  GADD45A protein plays an essential role in active DNA demethylation during terminal osteogenic differentiation of adipose-derived mesenchymal stem cells.

Authors:  Rui-peng Zhang; Jian-zhong Shao; Li-xin Xiang
Journal:  J Biol Chem       Date:  2011-09-14       Impact factor: 5.157

5.  A role for epigenetic changes in the development of retinal neurodegenerative conditions.

Authors:  Heather R Pelzel; Robert W Nickells
Journal:  J Ocul Biol Dis Infor       Date:  2012-03-20

6.  Comparison of gene-specific DNA methylation patterns in equine induced pluripotent stem cell lines with cells derived from equine adult and fetal tissues.

Authors:  Catherine H Hackett; Line Greve; Kira D Novakofski; Lisa A Fortier
Journal:  Stem Cells Dev       Date:  2011-11-21       Impact factor: 3.272

7.  Role of DNMT3B in the regulation of early neural and neural crest specifiers.

Authors:  Kristen Martins-Taylor; Diane I Schroeder; Janine M LaSalle; Marc Lalande; Ren-He Xu
Journal:  Epigenetics       Date:  2012-01-01       Impact factor: 4.528

8.  Epigenetic deregulation of the human Oct4 promoter in mouse cells.

Authors:  Young Cha; Min-Kyung Sung; Kyung-Won Jung; Hwan-Hee Kim; Su-Man Lee; Kyung-Soon Park
Journal:  Dev Genes Evol       Date:  2008-09-23       Impact factor: 0.900

9.  Epigenetic mechanisms regulate stem cell expressed genes Pou5f1 and Gfra1 in a male germ cell line.

Authors:  Maren Godmann; Erin May; Sarah Kimmins
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

10.  Epigenetic signatures associated with different levels of differentiation potential in human stem cells.

Authors:  Pablo Aranda; Xabier Agirre; Esteban Ballestar; Enrique J Andreu; José Román-Gómez; Inés Prieto; José Ignacio Martín-Subero; Juan Cruz Cigudosa; Reiner Siebert; Manel Esteller; Felipe Prosper
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.